GL1X · GenesisL1 explorer

MolNFT v1 · #163927 · protein

P53 cancer mutant Y220C in complex with small-molecule stabilizer PK9323

6SI0 · Cellular tumor antigen P53: “P53 cancer mutant Y220C in complex with small-molecule stabilizer PK9323”. X-ray diffraction, 2 ligands (LEK, ZN), 4 pockets (best druggability 0.68). MolNFT v1 #163927 on GenesisL1: 3D structure…

PDB
6SI0
Type
protein
Length
395 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Cellular tumor antigen P53
UniProt
P04637
Ligands
LEK, ZN
Pockets
4 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 8% helix, 33% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ACellular tumor antigen P53protein1978% helix, 33% strandP04637
BCellular tumor antigen P53protein1988% helix, 33% strandP04637

Ligands and binding sites

  • LEK · 1-[9-ethyl-7-(1,3-thiazol-4-yl)carbazol-3-yl]-~{N}-methyl-methanamine · ligand · 2 copies · chains A, B
  • ZN · Zinc ion · metal · 2 copies · chains A, B
  • EDO · 1,2-ethanediol · additive · chains A
  • GOL · Glycerol · additive · chains B
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
16010.680.7772EDO, EPE
2700.430.8117LEK
3640.380.7918LEK
4900.360.7519empty

Interfaces

1 interface between chains.

  • A–B · 300 Ų buried · 2 hydrogen bonds · protein-protein

Compared structures

  • 6SI0 · p53 cancer mutant Y220C in complex with small-molecule stabilizer PK9323 · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.